Sarcopenia; quality of life; translation; validation; Activities of Daily Living; Aged; Cross-Sectional Studies; Humans; Hungary; Language; Mass Screening; Quality of Life; Reproducibility of Results; Surveys and Questionnaires; Sarcopenia/diagnosis; Sarcopenia/epidemiology; Aging; Geriatrics and Gerontology; Physiology (medical); General Medicine
Abstract :
[fr] [en] BACKGROUND: Following the publication of a culturally adapted version of the original SarQoL® questionnaire in Hungarian language, we aimed to test its psychometric properties and its association with the SARC-F screening instrument.
DESIGN: This cross-sectional validation study recruited elderly people from 2 nursing homes and an endocrinology clinic. All participants were screened for sarcopenia with the SARC-F tool, had their muscle mass measured with bioelectrical impedance analysis, as well as grip strength and gait speed. Sarcopenia was diagnosed with the EWGSOP2 criteria. Participants completed the SarQoL questionnaire, the SF-36, the EQ-5D and the EQ-VAS. Validation consisted of analyzing discriminative power, internal consistency, construct validity and floor- and ceiling effects. A multivariate regression model was used to evaluate the association between QoL, the SARC-F questionnaire, and a number of demographic and clinical variables.
RESULTS: A total of 70 participants, aged 80.00 (68.50 - 82.50) years, were included. Discriminative power between sarcopenic and nonsarcopenic subjects was found for all domains, except domain 7 (Fears) when dividing study population based on the SARC-F score. We also found significantly lower QoL for domains 4 (Functionality) and 5 (Activities of daily living) when splitting participants based on muscle strength (Probable sarcopenia - EWGSOP2 definition). All domains showed a strong or moderate correlation with the total SarQoL score. Conceptually similar domains of other generic QoL questionnaires significantly correlated with the total SarQol score, confirming its convergent validity. Low correlations were found with different domains (divergent validity). No floor or ceiling effects were observed. Using a regression model, the components "strength" and "stair climbing" of the SARC-F questionnaire were significantly associated with the QoL of our patients assessed with the SarQoL instrument.
CONCLUSION: Sarcopenia risk assessed with the Sarc-F instrument was significantly associated with QoL measured with the SarQol questionnaire. High internal consistency, convergent and divergent validity and no floor and ceiling effects characterised the Hungarian language SarQoL® questionnaire. Due to some limitations, further multi-center designed studies are needed to verify the validity of the SarQol questionnaire.
Disciplines :
Geriatrics
Author, co-author :
Geerinck, Anton ; Université de Liège - ULiège > Université de Liège - ULiège
Demián, M-B; Department of Public Health and Health Management, University of Medicine, Pharmacy, Science, and Technology of Târgu Mureş, Târgu Mureş, Belgium
Beaudart, Charlotte ; Centre Hospitalier Universitaire de Liège - CHU > > Service de médecine de l'appareil locomoteur
Gasparik, A-I; Department of Public Health and Health Management, University of Medicine, Pharmacy, Science, and Technology of Târgu Mureş, Târgu Mureş, Belgium
Language :
English
Title :
Validation of the Hungarian Version of the SarQoL® Questionnaire and Its Association with the SARC-F Screening Tool.
Publication date :
2022
Journal title :
Journal of Frailty and Aging
ISSN :
2260-1341
eISSN :
2273-4309
Publisher :
Serdi-Editions, France
Volume :
11
Issue :
3
Pages :
267 - 273
Peer reviewed :
Peer reviewed
Funding text :
The authors certify that they comply with the ethical guidelines for authorship and publishing of the journal. All human studies have been approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki. *The first and the last author provided the same, first-author-level contribution to this work.
Rosenberg IH, Roubenoff R. Stalking sarcopenia. Ann Intern Med. 1995;123(9):727–728. doi:10.7326/0003-4819-123-9-199511010-00014 DOI: 10.7326/0003-4819-123-9-199511010-00014
Cruze Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010;39:412–423. DOI: 10.1093/ageing/afq034
Cruz-Jentoft AJ, Bahat G, Bauer J et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;4: 16–31. DOI: 10.1093/ageing/afy169
Morley JE, Baumgartner RN, Roubenoff R et al. Sarcopenia. J Lab Clin Med 2001; 137:231e243. DOI: 10.1067/mlc.2001.113504
Bauer JM, Kaiser MJ, Sieber CC. Sarcopenia in nursing home residents. J Am Med Dir Assoc 2008;9:545e551. DOI: 10.1016/j.jamda.2008.04.010
Fielding RA, Vellas B, Evans WJ et al. Sarcopenia: An undiagnosed condition in older adults. Current consensus definition: Prevalence, etiology, and consequences. International Working Group on Sarcopenia. J Am Med Dir Assoc 2011;12:249e256. DOI: 10.1016/j.jamda.2011.01.003
Malmstrom TK, Morley, JE. SARC-F: A Simple Questionnaire to Rapidly Diagnose Sarcopenia. Jamda 2013;14(8): 531–532.
Woo J, Leung J, Morley JE. Defining sarcopenia in terms of incident adverse outcomes. J Am Med Dir Assoc. 2015;16(3):247–252. doi:10.1016/j.jamda.2014.11.013. DOI: 10.1016/j.jamda.2014.11.013
Beaudart C, Reginster JY, Petermans J et al. Quality of life of sarcopenic patients: contribution of the SarcoPhAge study. Geriatr Psychol Neuropsychiatr Vieil. 2015;13(4):391–395.
Rizzoli R, Reginster JY, Arnal JF et al. Quality of life in sarcopenia and frailty. Calcif Tissue Int 2013;93:101–120. 10.1007/s00223-013-9758-y. DOI: 10.1007/s00223-013-9758-y
Beaudart C, Biver E, Reginster J-Y et al. Development of a self-administrated quality of life questionnaire for sarcopenia in elderly subjects: the SarQoL. Age Ageing. 2015; 44: 960–966. DOI: 10.1093/ageing/afv133
Beaudart C, Biver E, Reginster J-Y et al. Validation of the SarQoL, a specific health-related quality of life questionnaire for Sarcopenia. J Cachexia Sarcopenia Muscle 2017; 8: 238–244. DOI: 10.1002/jcsm.12149
Beaudart C, Edwards M, Moss C et al. English translation and validation of the SarQoL®, a quality of life questionnaire specific for sarcopenia. Age Ageing 2017; 46: 271–277.
Geerinck A, Alekna V, Beaudart C et al. Standard error of measurement and smallest detectable change of the Sarcopenia Quality of Life (Sarqol) questionnaire: An analysis of subjects from 9 validation studies. PLoS One 2019; 14: e0216065. DOI: 10.1371/journal.pone.0216065
Geerinck A, Scheppers A, Beaudart C et al. Translation and validation of the Dutch SarQoL ®, a quality of life questionnaire specific to sarcopenia. J Musculoskelet Neuronal Interact 2018; 18: 463–472.
Tsekoura M, Billis E, Gliatis J et al. Cross cultural adaptation of the Greek sarcopenia quality of life (SarQoL) questionnaire. Disabil Rehabil 2020; 42(7): 1006–1012. DOI: 10.1080/09638288.2018.1514076
Konstantynowicz J, Abramowicz P, Glinkowski W et al. Polish Validation of the SarQoL®, a Quality of Life Questionnaire Specific to Sarcopenia. J Clin Med 2018; 7: 323. DOI: 10.3390/jcm7100323
Alekna V, Kilaite J, Tamulaitiene M et al. Validation of the Lithuanian version of sarcopenia-specific quality of life questionnaire (SarQoL®). Eur Geriatr Med 2019; 10: 761–767 DOI: 10.1007/s41999-019-00208-x
Safonova YA, Lesnyak OM, Baranova IA et al. Russian translation and validation of SarQoL® - quality of life questionnaire for patients with sarcopenia. Nauchno-Prakticheskaya Revmatol 2019; 57: 38–45. DOI: 10.14412/1995-4484-2019-38-45
Fábrega-Cuadros R, Martínez-Amat A, Cruz-Díaz D et al. Psychometric Properties of the Spanish Version of the Sarcopenia and Quality of Life, a Quality of Life Questionnaire Specific for Sarcopenia. Calcif Tissue Int 2020; 106: 274–282. DOI: 10.1007/s00223-019-00635-9
Geerinck A, Bruyère O, Locquet M et al. Evaluation of the Responsiveness of the SarQoL® Questionnaire, a Patient-Reported Outcome Measure Specific to Sarcopenia. Adv Ther 2018; 35: 1842–1858. DOI: 10.1007/s12325-018-0820-z
Gasparik AI, Mihai G, Beaudart C et al. Correction to: Psychometric performance of the Romanian version of the SarQoL(R), a health-related quality of life questionnaire for sarcopenia. Arch. Osteoporos. 2018; 13: 98. DOI: 10.1007/s11657-018-0516-7
Gasparik A, Mihai G, Pascanu MI. Romanian translation and cross-cultural adaptation of the SarQol Questionnaire. Acta Med Marisiensis 2016; 62: 384–385. DOI: 10.1515/amma-2016-0036
Hodinka L, Vereckei E, Gasparik AI. Sarcopenia and quality of life: the validated Hungarian translation of the Sarcopenia Quality of Life (SarQoL) questionnaire. Orvosi Hetilap 2018;159(36):1483–1486. DOI: 10.1556/650.2018.31157
Malmstrom TK, Morley JE, Sarc-F: A simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc. 2013;14(8):531–2. DOI: 10.1016/j.jamda.2013.05.018
Dehghan M, Merchant AT. Is bioelectrical impedance accurate for use in large epidemiological studies? Nutr J. 2008; 7: 26. Published online 2008 Sep 9. doi: 10.1186/1475-2891-7-26. DOI: 10.1186/1475-2891-7-26
Gasparik AI, Demian MB, Pascanu I, Romanian Translation and Validation of the SARC-F Questionnaire, Acta Endo (Buc) 2020;16 (2): 216–222. DOI: 10.4183/aeb.2020.216
Gasparik AI, Demian MB, Pascanu I et al. Evaluation of the Hungarian-language SARC-F sarcopenia screening questionnaire, Orvosi Hetilap. 2020;161 (47): 2005–2010. DOI: 10.1556/650.2020.31932
Geerinck A, Beaudart C, Locquet M et al. Association between SARC-F and quality of life measured with the SarQoL® questionnaire in older, community-dwelling subjects from the SarcoPhAge cohort. Consulted on https://www.wco-iof-esceo.org/sites/wco20/pdf/WCO20-AbstractBook.pdf
